Sponsor

Dexa Medica Group

Clinical research sponsor

Published trials10

Recruiting shown0

Roles2

SourceClinicalTrials.gov

Clinical trials

10 shown

DLBS1449 in Diabetic Patients With Low HDLNCT01972477 · lead sponsor · 2016-07-01

WITHDRAWN

DLBS1033 Treatment in Diabetic With Peripheral Arterial DiseaseNCT02145988 · lead sponsor · 2015-06-03

TERMINATED

Efficacy and Safety of DLBS1033 in Subjects With Type 2 Diabetes MellitusNCT01865474 · lead sponsor · 2013-05-01

COMPLETED

Efficacy and Safety of DLBS3233 in Subjects With New Onset of Type 2 Diabetes MellitusNCT01645332 · lead sponsor · 2012-07-01

COMPLETED

Efficacy and Safety of DLBS3233 in Prediabetic PatientsNCT01531933 · lead sponsor · 2011-11-01

COMPLETED

Efficacy and Safety of Add-on Therapy With DLBS3233 in Patients With Type-2 Diabetes MellitusNCT01472614 · lead sponsor · 2011-09-01

COMPLETED

Efficacy and Safety of DLBS1425 as Neoadjuvant in Stage II or III Breast Cancer PatientsNCT01433562 · lead sponsor · 2011-08-01

COMPLETED

Efficacy of DLBS-32 in Subjects With Type-II Diabetes MellitusNCT01005069 · lead sponsor · 2009-10-01

COMPLETED

Efficacy and Safety of DLBS1425 in Subjects With Advanced/Metastatic Breast CancerNCT01006785 · lead sponsor · 2009-08-01

TERMINATED

The Effect of Oral DLBS1033 in Patients With Diabetic PolyneuropathyNCT07475065 · collaborator · 2026-03-01

NOT_YET_RECRUITING

Sponsor roles

lead sponsor9

collaborator1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.